tiletamine hydrochloride has been researched along with Uveitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, Y; Hirakata, A; Keino, H; Kudo, A; Okada, AA; Umezawa, K | 1 |
| Ishida, S; Iwabuchi, K; Iwata, D; Kitaichi, N; Miyazaki, A; Namba, K; Ohno, S; Onoé, K; Ozaki, M; Todo, S; Umezawa, K; Yamashita, K; Yoshida, K | 1 |
2 other study(ies) available for tiletamine hydrochloride and Uveitis
| Article | Year |
|---|---|
Anti-Inflammatory Effect of Dehydroxymethylepoxyquinomicin, a Nuclear factor-κB Inhibitor, on Endotoxin-Induced Uveitis in Rats In vivo and In vitro.
Topics: Animals; Aqueous Humor; Benzamides; Cells, Cultured; Cyclohexanones; Disease Models, Animal; Immunohistochemistry; Male; NF-kappa B; Rats, Inbred Lew; Treatment Outcome; Uveitis | 2020 |
Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
Topics: Animals; Antigen-Presenting Cells; Autoimmune Diseases; Benzamides; Cell Nucleus; Cyclohexanones; Cytokines; Disease Models, Animal; Down-Regulation; Female; Fluorescent Antibody Technique, Indirect; Injections, Intraperitoneal; Lymphocyte Activation; Mice; Microscopy, Confocal; Retina; Retinitis; T-Lymphocytes; Transcription Factor RelA; Uveitis | 2010 |